NEUROPATHIC PAIN: REDEFINITION AND A GRADING SYSTEM FOR CLINICAL AND RESEARCH PURPOSES

By J. Ochoa. Neurology, 2009

1,448 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Neuropathic Pain (2009, background): “N eu ro g by U ni ve rs”
Neuropathic pain in the general population: A systematic review of epidemiological studies (2014, background): “This is based on a combination of plausible distribution and history of pain, other positive confirmatory tests, and clinical investigation(s) by a pain specialist or neurologist [39].”
TFOS DEWS II pain and sensation report (2017, neutral): “Neuropathic pain is defined by the IASP as pain caused by a lesion or disease of the somatosensory nervous system, in contrast with nociceptive pain produced by the normal function of nociceptors.”
The evidence for pharmacological treatment of neuropathic pain (2010, background): “system” [105], constitutes a rather well-described symptom constellation despite diversities in causes and anatomy.”
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision (2010, background): “Background and objectives Neuropathic pain (NP) may be caused by a lesion or a disease of the somatosensory system [1] and is estimated to afflict as high as 7–8% of the general population in Europe [2,3].”